Amarin Huntington’s Disease Agent To Be Named Eico Or Lxia?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Amarin has submitted the names Eico and Lxia to the Patent and Trademark Office as potential tradenames for its Huntington’s Disease agent, LAX-101 (ethyl eicosapentaenoate).